新生儿肺出血高危因素及治疗的研究进展  

Research Progress on Risk Factors and Treatment of Neonatal Pulmonary Hemorrhage

作　　者：廖燕 黄国盛 陆岸锋 LIAO Yan;HUANG Guosheng;LU Anfeng(Qinzhou Meternal and Child Health Care Hospital,Guangxi,Qinzhou 535099,China)

机构地区：[1]广西钦州市妇幼保健院,广西钦州535099

出　　处：《中国医学创新》2023年第17期175-179,共5页Medical Innovation of China

基　　金：钦州市科研与技术开发计划项目(20211209,20211206)。

摘　　要：新生儿肺出血(pulmonary hemorrhage,PH)是指新生儿期肺大量出血,是新生儿主要的危重症之一,死亡率高。如何早期识别新生儿PH的高危因素,积极采取有效措施,降低病死率是临床研究的热点。笔者拟对新生儿PH的高危因素和治疗的最新进展进行阐述。Neonatal pulmonary hemorrhage(PH)refers to massive pulmonary hemorrhage during the neonatal period,which is one of the major critical diseases of neonates with a high mortality rate.How to identify the risk factors of PH early and taking effective measures to reduce the mortality rate is a hot spot in clinical research.This paper reviews the literature on the risk factors and treatment of neonatal pulmonary hemorrhage.

关 键 词：新生儿 肺出血 高危因素 

分 类 号：R722.1[医药卫生—儿科]